市售人纤维蛋白原质量评价OA
Quality Evaluation of Commercially Available Human Fibrinogen
目的 评价市售人纤维蛋白原的质量现状,比较不同企业产品内在差异.方法 对 7 家企业 21 批样品依据法定质量标准进行关键项目检验,同时开展血源性病毒(人细小病毒B19 和巨细胞病毒)残留考察、稳定性研究、杂蛋白研究和铝离子残留考察等 4 个方面的探索性研究.对按法定标准检验结果和探索性研究结果进行统计分析,综合评价人纤维蛋白原质量状况.结果 21 批样品法定标准检验合格率 100%.探索性研究结果显示,人巨细胞病毒DNA残留均为阴性,38%的样品检出人细小病毒B19 DNA残留;不同企业产品的热稳定性差异较大,可能与保护剂有关,热稳定性较好的产品纯度较高;7 家企业共鉴定出杂蛋白 3~10 种,不同企业纤连蛋白和纤溶酶原含量均较低;1 家企业因工艺采用氢氧化铝凝胶吸附,铝离子残留量显著高于其他企业.结论 市售人纤维蛋白原整体质量状况良好,但仍需要加强人细小病毒B19 载量控制,并通过逐步完善处方和工艺,提高产品稳定性,降低杂蛋白和铝离子残留等风险.该研究为提高市售人纤维蛋白原的质量提供了技术支撑.
Objective To evaluate the quality status of commercially available fibrinogen and compare the inherent differences in products from different enterprises.Methods A total of 21 batches of samples from 7 companies were inspected accord legal quality standards,and research was conducted on four aspects:residual investigation of borne viruses(human parvo-virus B19 and cytomegalovirus),stability,protein composition,and aluminum ion residue.Conduct statistical analysis on the results of testing according to legal standards and exploratory comprehensively evaluate the quality status of human fibrinogen.Results The legal standard inspection pass rate of 21 batches of samples was 100%.The exploratory research results showed that the re-sidual DNA of human cytomegalovirus was negative,and 38%of the samples were detected to have residual DNA of human parvo-virus B19.The thermal stability of products from different enterprises varies greatly,which may be related to protective agents,with higher purity observed in products exhibiting better thermal stability.A total of 3 to 10 heteroproteins were identified across the 7 manufacturers,with low levels of fibronectin and plasminogen in all products.One enterprise used aluminum hydroxide gel for adsorption,and the residual aluminum ion was significantly higher of other enterprises.Conclusions The overall quality of this product is good,but there is still a need to strengthen control of human parvovirus B19 load and gradually improve and process to enhance product stabilityrisks of impurities and aluminum ion residues.The research can provid technical support for enhancing the quality of commercially available human fibrinogen.
王文晞;郭江红;王德蓉;李世兴;程梦兰;谢育媛;胡敏
湖北省药品监督检验研究院(湖北生物制品检定所),武汉 430075湖北省药品监督检验研究院(湖北生物制品检定所),武汉 430075湖北省药品监督检验研究院(湖北生物制品检定所),武汉 430075湖北省药品监督检验研究院(湖北生物制品检定所),武汉 430075湖北省药品监督检验研究院(湖北生物制品检定所),武汉 430075湖北省药品监督检验研究院(湖北生物制品检定所),武汉 430075湖北省药品监督检验研究院(湖北生物制品检定所),武汉 430075
医药卫生
人纤维蛋白原质量评价血源性病毒残留热稳定性铝离子残留
Human fibrinogenQuality evaluationResidual blood borne virusesThermal stabilityAluminum ion resi-dues
《医药导报》 2026 (5)
796-802,7
国家药品抽检计划项目.
评论